南京招聘

职位描述：
Job Responsibilities:
？Lead out-licensing efforts for a pipeline of early stage antibody discovery and development, including identifying potential clients/partners, developing and delivering pitch presentations, managing diligence process and structuring, negotiating and closing license agreements
？Build a pipeline of technology license deal opportunities by targeting the appropriate partners, promoting H3- and SynAb- technology, identifying collaboration opportunities and structuring, negotiating and closing license agreements
？Positioning Biosynergics’ proprietary antibody platform and capabilities in the biopharmaceutical industry
？In conjunction with marketing, identify and develop new antibody drug development opportunities (from pipeline/drug tracking information or company start up level)
？Work with marketing to track and report progress metrics for penetration of drug pipeline
？Monitoring and reporting progress towards achieving projection (specification wins, sales)
？Generate sales leads and opportunities; Able to prioritize, set and achieve targets.

Qualification requirements
？MS degree or PhD degree in biology and/or medical science
？5+ years of biotech business development and licensing experience
？Experience and demonstrated track record in both product out-licensing and technology platform out-licensing
？Strong fundamental strategic, commercial and deal negotiation skills; ability to appropriately evaluate and pursue strategic deals for the business
？Strong oral and written communication skills; ability to listen and communicate effectively with internal team members and management
？Proven ability to organize and plan work and balance multiple priorities effectively meet deadlines
？Strong fundamental strategic, commercial and deal negotiation skills; ability to appropriately evaluate and pursue strategic deals for the business. 举报 分享

    南京博斯金生物技术有限公司（Biosynergics Inc.）是一家专注于开发治疗和诊断用抗体的创新型生物技术公司。 依托其专有的整合型抗体开发技术平台（H3抗体技术、协同抗体技术［SynAb?］、抗体人源化技术以及细胞工程技术等），博斯金生物致力于开发新一代性能独特、产品多样、拥有自主知识产权的治疗(FIC&BIC)或诊断用抗体产品。
    本公司运营管理团队由资深抗体专家和具有国际视野的高级管理人员共同组成。公司创始人、总经理陈明久博士拥有近20年海外抗体开发实战经验，曾任美国战略诊断公司（SDIX）资深运营总监，艾伯维公司（Abbvie）资深研究员，曾带领团队完成100多项诊断用及治疗用抗体开发商业服务项目，客户涵盖几十家国际知名跨国制药公司和诊断试剂公司。自2013年创立以来，公司先后获得 “南京321人才计划”项目重点扶持、清华大学专项投资、以及多项天使投资。公司成立以来，成功开发了系列诊断用抗体产品，建立了多项治疗用抗体合作项目，并与国内外多家知名生物制药公司和诊断试剂公司建立了稳定的业务关系。
    公司秉承“创新进取，客户至上”的经营理念，追求多元互补的协同加合效应，以期实现创新与产品产业化高效转化。通过建立国际一流的技术团队和管理团队，博斯金生物致力于开发性能卓越具有国际竞争力的生物技术产品，服务于全球生命科学领域，造福于人类健康福祉。